Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'p53 and mdm2 proteins interaction inhibitor racemic'

Search results for: 'p53 and mdm2 proteins interaction inhibitor racemic'

Items 41-50 of 62

Page
per page
  1. Pitavastatin Calcium
    A8504 Pitavastatin Calcium
     1 Citation
    Target: HMG-CoA Reductases
    Summary: Enzyme HMGCR inhibitor
      ≥34.85 mg/mL
  2. Varespladib (LY315920)
    A4356 Varespladib (LY315920)
    Target: Phospholipases
    Summary: HnsPLA inhibitor,potent and selective
  3. AZD7687
    A3215 AZD7687
    Target: DGAT
    Summary: DGAT inhibitor,potent and selective
      Soluble in DMSO
  4. Tolcapone
    A4383 Tolcapone
    Target: Catechol O-Methyltransferase (COMT)
    Summary: COMT inhibitor
      insoluble in H2O; ≥12 mg/mL
  5. CBR-5884
    A8721 CBR-5884
     1 Citation
    Target: 3-phosphoglycerate dehydrogenase
    Summary: selective inhibitor of PHGDH
      insoluble in EtOH; insoluble in H2O; ≥16.8 mg/mL
  6. GGsTop
    B5602 GGsTop
    Summary: γ-glutamyl transpeptidase (GGT) inhibitor, novel and irreversible
      <6.63 mg/mL
  7. Methazolamide
    A4364 Methazolamide
    Target: Carbonic Anhydrases
    Summary: Carbonic anhydrase inhibitor
  8. Indoximod (NLG-8189)
    B4900 Indoximod (NLG-8189)
    Summary: Indoleamine 2,3-dioxygenase (IDO) pathway inhibitor
      insoluble in DMSO; insoluble in EtOH; ≥1.12 mg/mL
  9. Vardenafil HCl Trihydrate
    A4323 Vardenafil HCl Trihydrate
    Target: Phosphodiesterases (PDEs)
    Summary: PDE5 inhibitor, potent and selective
      ≥13.3 mg/mL
  10. Tadalafil
    A4327 Tadalafil
    Target: Phosphodiesterases (PDEs)
    Summary: PDE5 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥16.6 mg/mL

Items 41-50 of 62

Page
per page
Shop By
Now Shopping by
  1. Category Metabolism Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Aminopeptidase 1 item
  2. Carbonic Anhydrase 3item
  3. CETP 2item
  4. CYP3A/CYP450 1 item
  5. Dehydrogenase 4item
  6. DGAT 1 item
  7. Dopamine β-hydroxylase 2item
  8. FAAH 1 item
  9. Factor Xa 1 item
  10. Ferroptosis 1 item
  11. HMG-CoA Reductase 5item
  12. HSP 9item
  13. IDO 3item
  14. KRAS-PDEδ 1 item
  15. Lipid Metabolism 1 item
  16. P450 3item
  17. PDE 12item
  18. Phospholipase 2item
  19. SCD 1 item
  20. SGLT 1 item
  21. Transferase 6item
  22. monooxygenase 1 item
Reversibility
  1. Reversible 1 item
  2. Irreversible 3item
Target
  1. Acyl coenzyme A: cholesterol acyltransferases 1 item
  2. Factor Xa 1 item
  3. Phosphodiesterases (PDEs) 10item
  4. 3-phosphoglycerate dehydrogenase 1 item
  5. Kynurenine-3-monooxygenase 1 item
  6. Aminopeptidases 1 item
  7. Stearoyl-CoA 9-desaturase (SCD-1) 1 item
  8. HSP90 7item
  9. Cytochrome P450 (CYP450) 3item
  10. Ferroptosis 1 item
  11. HMG-CoA Reductases 5item
  12. SGLT 1 item
  13. DGAT 2item
  14. CETP 2item
  15. Lactate Dehydrogenases (LDH) 2item
  16. Fatty-acid-binding proteins (FABPs) 1 item
  17. IDH2 1 item
  18. Nampt 1 item
  19. Carbonic Anhydrases 3item
  20. Aldehyde Dehydrogenases 1 item
  21. Phospholipases 1 item
  22. Catechol O-Methyltransferase (COMT) 1 item
  23. FPTase 1 item
  24. Ftase 1 item
  25. FAAH 1 item
  26. IDO 1 item
  27. Glycogen Phosphorylases 1 item
Reported Experiments
  1. Animal Experiments 58item
  2. Cell Experiments 42item
Related Disease
  1. Acne 1 item
  2. Acute Myelogenous Leukemia 1 item
  3. Acute Myeloid Leukemia 2item
  4. Bladder Carcinoma 1 item
  5. Brain Injuries Studies 1 item
  6. Breast Cancer 8item
  7. Cancer 25item
  8. Chronic Lymphocytic Leukemia 1 item
  9. Cocaine-Related Disorders 2item
  10. Colon Cancer 1 item
  11. Diabetes 2item
  12. Dyslipidemia 1 item
  13. Epilepsy 1 item
  14. Erectile Dysfunction 3item
  15. Glioblastoma 1 item
  16. Glioma 1 item
  17. Hepatic Cancer 1 item
  18. HIV Infections 1 item
  19. Hypercholesterolemia 2item
  20. Inflammation 1 item
  21. Inflammatory Diseases 1 item
  22. Leukemia 1 item
  23. Lung Cancer 3item
  24. Lymphoma 1 item
  25. Melanoma 7item
  26. Multiple Myeloma 2item
  27. Neuroblastoma 2item
  28. Neurocognitive Disorders 1 item
  29. Non-small Cell Lung Cancer 2item
  30. Obsessive-Compulsive Disorder 1 item
  31. Osteoporosis 1 item
  32. Pancreatic Cancer 2item
  33. Pancreatic Carcinoma 1 item
  34. Prostate Cancer 7item
  35. Psoriasis 2item
  36. Psoriasis Vulgaris 1 item
  37. Pulmonary Arterial Hypertension 1 item
  38. Rheumatoid Arthritis 1 item
  39. Schizophrenia 2item
  40. Type 2 Diabetes 2item